Compare LZB & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LZB | AMPH |
|---|---|---|
| Founded | 1927 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1994 | 2005 |
| Metric | LZB | AMPH |
|---|---|---|
| Price | $29.54 | $25.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $41.00 | $22.50 |
| AVG Volume (30 Days) | ★ 673.5K | 448.0K |
| Earning Date | 11-17-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.28% | N/A |
| EPS Growth | ★ 5.11 | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | ★ $2,349,433,000.00 | $719,887,000.00 |
| Revenue This Year | N/A | $3.87 |
| Revenue Next Year | $3.50 | $4.90 |
| P/E Ratio | ★ N/A | $31.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.79 | $16.65 |
| 52 Week High | $44.90 | $29.52 |
| Indicator | LZB | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 32.87 | 56.60 |
| Support Level | N/A | $23.45 |
| Resistance Level | $36.50 | $29.40 |
| Average True Range (ATR) | 0.77 | 1.01 |
| MACD | 0.23 | -0.09 |
| Stochastic Oscillator | 37.56 | 37.59 |
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.